JAGX
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Feb 26, 6:59 PM EST
VXRT
Price
$1.23
Change
-$0.04 (-3.15%)
Updated
Feb 26, 6:59 PM EST
77 days until earnings call
Ad is loading...

JAGX vs VXRT ᐉ Comparison: Which is Better to Invest?

Header iconJAGX vs VXRT Comparison
Open Charts JAGX vs VXRTBanner chart's image
Jaguar Health
Price$0.06
Change-$0.00 (-0.00%)
Volume$11.44M
CapitalizationN/A
Vaxart
Price$1.23
Change-$0.04 (-3.15%)
Volume$1.24M
CapitalizationN/A
View a ticker or compare two or three
JAGX vs VXRT Comparison Chart

Loading...

JAGXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VXRTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
JAGX vs. VXRT commentary
Feb 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAGX is a Hold and VXRT is a Hold.

COMPARISON
Comparison
Feb 27, 2024
Stock price -- (JAGX: $0.06 vs. VXRT: $1.23)
Brand notoriety: JAGX and VXRT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JAGX: 130% vs. VXRT: 86%
Market capitalization -- JAGX: $3.05M vs. VXRT: $194.83M
JAGX [@Biotechnology] is valued at $3.05M. VXRT’s [@Biotechnology] market capitalization is $194.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $550.21B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JAGX’s FA Score shows that 1 FA rating(s) are green whileVXRT’s FA Score has 0 green FA rating(s).

  • JAGX’s FA Score: 1 green, 4 red.
  • VXRT’s FA Score: 0 green, 5 red.
According to our system of comparison, VXRT is a better buy in the long-term than JAGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JAGX’s TA Score shows that 3 TA indicator(s) are bullish while VXRT’s TA Score has 5 bullish TA indicator(s).

  • JAGX’s TA Score: 3 bullish, 4 bearish.
  • VXRT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VXRT is a better buy in the short-term than JAGX.

Price Growth

JAGX (@Biotechnology) experienced а -23.18% price change this week, while VXRT (@Biotechnology) price change was +2.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.08%. For the same industry, the average monthly price growth was +16.73%, and the average quarterly price growth was +41.60%.

Reported Earning Dates

JAGX is expected to report earnings on May 19, 2023.

VXRT is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (+4.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for JAGX with price predictions.
OPEN
A.I.dvisor published
a Summary for VXRT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VXRT($195M) has a higher market cap than JAGX($3.05M). VXRT YTD gains are higher at: 114.735 vs. JAGX (-60.370). JAGX has higher annual earnings (EBITDA): -29.66M vs. VXRT (-79.83M). VXRT has more cash in the bank: 52.2M vs. JAGX (3.23M). VXRT has less debt than JAGX: VXRT (20.5M) vs JAGX (35.5M). JAGX has higher revenues than VXRT: JAGX (10.7M) vs VXRT (776K).
JAGXVXRTJAGX / VXRT
Capitalization3.05M195M2%
EBITDA-29.66M-79.83M37%
Gain YTD-60.370114.735-53%
P/E RatioN/AN/A-
Revenue10.7M776K1,379%
Total Cash3.23M52.2M6%
Total Debt35.5M20.5M173%
FUNDAMENTALS RATINGS
JAGX vs VXRT: Fundamental Ratings
JAGX
VXRT
OUTLOOK RATING
1..100
5183
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9836
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JAGX's Valuation (31) in the Pharmaceuticals Generic industry is somewhat better than the same rating for VXRT (65) in the Biotechnology industry. This means that JAGX’s stock grew somewhat faster than VXRT’s over the last 12 months.

JAGX's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as VXRT (100) in the Biotechnology industry. This means that JAGX’s stock grew similarly to VXRT’s over the last 12 months.

VXRT's SMR Rating (98) in the Biotechnology industry is in the same range as JAGX (100) in the Pharmaceuticals Generic industry. This means that VXRT’s stock grew similarly to JAGX’s over the last 12 months.

VXRT's Price Growth Rating (36) in the Biotechnology industry is somewhat better than the same rating for JAGX (98) in the Pharmaceuticals Generic industry. This means that VXRT’s stock grew somewhat faster than JAGX’s over the last 12 months.

VXRT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as JAGX (100) in the Pharmaceuticals Generic industry. This means that VXRT’s stock grew similarly to JAGX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JAGXVXRT
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
JAGXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VXRTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RSSS2.990.05
+1.70%
Research Solutions
EQBK32.310.42
+1.32%
Equity Bancshares
ROKU64.35-0.13
-0.20%
Roku
FRME33.66-0.47
-1.38%
First Merchants Corp
AGRX0.81-0.08
-9.19%
Agile Therapeutics

JAGX and

Correlation & Price change

A.I.dvisor tells us that JAGX and HEPA have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JAGX and HEPA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAGX
1D Price
Change %
JAGX100%
N/A
HEPA - JAGX
29%
Poorly correlated
-3.31%
PIRS - JAGX
28%
Poorly correlated
+2.09%
LGVN - JAGX
28%
Poorly correlated
+4.25%
VXRT - JAGX
28%
Poorly correlated
-3.15%
SRNEQ - JAGX
27%
Poorly correlated
-71.72%
More